Comprehensive Chromosomal Screening (CCS)

Comprehensive Chromosome Screening (CCS)

Comprehensive Chromosome Screening (CCS) is an advanced genetic test used during in vitro fertilization (IVF) to detect chromosomal abnormalities in embryos before implantation in the uterus. This screening analyzes all 23 pairs of chromosomes, helping to select the healthiest embryos to ensure a successful pregnancy and reduce the risk of miscarriage.

How is CCS Performed?

CCS is conducted as part of the IVF process through the following steps:

1. Egg Retrieval and Fertilization: Eggs are collected from the ovaries and fertilized in the laboratory using Intracytoplasmic Sperm Injection (ICSI).
2. Embryo Development in the Lab: The fertilized egg is allowed to develop until it reaches the blastocyst stage (on the fifth or sixth day after fertilization).
3. Biopsy for Screening: A few cells are carefully extracted from the embryo without affecting its growth or development.
4. Genetic Material Analysis: Advanced technologies, such as Next-Generation Sequencing (NGS), are used to analyze the chromosomes and ensure their integrity.
5. Selection of Healthy Embryos: Embryos with chromosomal abnormalities are excluded, and only genetically normal embryos are implanted to increase the chances of a successful pregnancy.

Importance of Comprehensive Chromosome Screening

• Enhancing IVF Success Rates: CCS helps select embryos with the highest implantation and development potential.
• Reducing Miscarriage Risk: It minimizes pregnancy loss due to chromosomal abnormalities.
• Detecting Genetic Syndromes: Such as Down syndrome, Turner syndrome, and Klinefelter syndrome.
• Increasing Healthy Pregnancy Rates: By selecting embryos with a normal genetic composition.
• Gender Selection When Necessary: CCS can be used to determine the gender of the embryo in specific medical or social cases.

Who Are the Ideal Candidates for CCS?

• Women over 35, as chromosomal abnormalities become more common with age.
• Couples with recurrent miscarriages or previous failed IVF attempts.
• Couples with a family history of genetic disorders.

Technologies Used in CCS

• Next-Generation Sequencing (NGS): A highly advanced technique offering high accuracy in DNA analysis and chromosomal screening.
• Fluorescence In Situ Hybridization (FISH): Used to analyze a limited number of chromosomes but is less accurate than NGS.
• Array Comparative Genomic Hybridization (aCGH): Compares embryonic DNA with a reference sample to detect chromosomal abnormalities.